FDA Approves Ultrasound Therapy to Treat Prostate Cancer December 3, 2015 The device is a single treatment intended for men in stage T-1 or T-2 of organ-confined prostate cancer. Read More
Greatbatch Wins PMA Approval for Spinal Cord Stimulation System December 2, 2015 The system is designed for the treatment of chronic intractable pain of the trunk and limbs. Read More
StimRelieve Receives IDE Approval to Launch Trial of Halo CFNS System December 2, 2015 The system is a small, implantable device for the treatment of refractory craniofacial neuropathic pain. Read More
FDA Green Lights Philosys’ Glucose Monitor for Android Users December 2, 2015 The system consists of a small, portable blood glucose meter that plugs into the headphone jack of a smartphone. Read More
Acelity Acquires SNaP Therapy System From Spiracur December 2, 2015 The system includes a disposable negative pressure wound therapy line of products designed to treat complex wounds. Read More
St. Jude Wins CE Mark for MR-Conditional Labeling for Resynchronization Device December 2, 2015 Patients who use the Quadra Assura cardiac resynchronization therapy defibrillator now can receive an MRI scan. Read More
Olympus Launches EZDilate Endoscopic Balloon Dilator December 1, 2015 The device aims for improved precision and control in endoscopic balloon dilation procedures. Read More
HiberGene Diagnostics Awarded CE Mark for Meningococcus Test December 1, 2015 The assay tests for Meningococcal disease, a severe form of bacterial meningitis. Read More
Caputron Launches mindGear Headset December 1, 2015 The device is indicated for the treatment of depression, insomnia and anxiety. Read More
Aeterna Zentaris to Distribute Armune’s Apifiny Test in the U.S. December 1, 2015 Apifiny is a non-PSA blood test for the detection of prostate cancer. Read More
Boston Scientific Receives FDA Approval, CE Mark for DVT Catheter December 1, 2015 The catheter is built to remove large venous clots and facilitate rapid restoration of blood flow. Read More
Micromedic, Axella Partner for Advancement of Bladder Cancer Test November 30, 2015 Axella will contribute more than $1 million in funding and provide key clinical research organization services. Read More